GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the omalizumab Fab SER81ARG, GLN83ARG and LEU158PRO light chain mutant

Analyse Crystal structure of the omalizumab Fab SER81ARG, GLN83ARG and LEU158PRO light… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6TCR
Type
protein
Length
428 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Omalizumab Fab SER81ARG, GLN83ARG and LEU158PRO light chain mutant
Pockets
3 · best druggability 0.61

Structure

x-ray diffraction · 2 distinct chains · 7% helix, 53% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
HOmalizumab Fab SER81ARG, GLN83ARG and LEU158PRO light chain mutantprotein2128% helix, 54% strand—
LOmalizumab Fab SER81ARG, GLN83ARG and LEU158PRO light chain mutantprotein2166% helix, 53% strand—

Ligands and binding sites

  • EDO · 1,2-ethanediol · additive · 8 copies · chains H, L
  • PEG · Di(hydroxyethyl)ether · additive · chains L

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15940.610.7356EDO
2640.530.8722empty
3540.340.7818empty

Interfaces

1 interface between chains.

  • H–L · 1787 Ų buried · 13 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 3 disulfide (disulfide).

Compared structures

  • 6TCR · Crystal structure of the omalizumab Fab Ser81Arg, Gln83Arg and Leu158Pro light chain… · the same entry in another collection · chain H against H, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.